Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00228358
Status:
COMPLETED
Last Update Posted:
2014-11-11
First Post:
2005-09-13
Brief Title:
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patients Own T Cells in the Laboratory in Treating Patients With HER-2Neu Overexpressing Metastatic Breast Cancer Ovarian Cancer or Non-Small Cell Lung Cancer Previously Treated With HER-2Neu Vaccine
Sponsor:
University of Washington
Organization:
University of Washington
Organization Data
Organization:
University of Washington
Class:
OTHER
Study ID:
6223
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Washington
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |